Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Everything You Need to Know: Pfizer, Bristol-Myers Squibb, VIVUS, Sarepta, and St. Jude

In this video, Motley Fool health-care analyst David Williamson talks about some of the biggest investing stories in the health-care space today. He tells us about Pfizer (NYSE: PFE  ) and Bristol-Myers Squibb's (NYSE: BMY  ) latest European victory, a major insurance win for obesity-drug maker VIVUS (Nasdaq: VVUS  ) , a huge vote of share-price confidence for Sarepta (Nasdaq: SRPT  ) and its drug for Duchenne muscular dystrophy, and a big tumble for St. Jude Medical (NYSE: STJ  ) after another problem with one of its products.

The ravages of America's obesity epidemic are a challenge of epic proportions. However, a group of drug companies is looking to change everything. Newly approved drugs, including one developed by VIVUS, could help to reverse this deadly course while reaping massive profits for investors in the process. The profit opportunity is immense, but plenty of risks still exist, so make sure you understand the full story behind VIVUS in the Fool's brand-new premium research service. It's such an important story that we have our top health-care writer on the job, so make sure to secure a copy today by clicking here now.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2124411, ~/Articles/ArticleHandler.aspx, 10/24/2016 10:42:39 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,233.47 87.76 0.48%
S&P 500 2,150.81 9.65 0.45%
NASD 5,304.26 46.85 0.89%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 10:27 AM
BMY $49.64 Down -0.38 -0.77%
Bristol-Myers Squi… CAPS Rating: ****
PFE $32.27 Up +0.09 +0.26%
Pfizer CAPS Rating: ****
SRPT $47.75 Down -0.23 -0.48%
Sarepta Therapeuti… CAPS Rating: **
STJ $79.54 Up +0.18 +0.23%
St. Jude Medical CAPS Rating: **
VVUS $1.11 Up +0.01 +0.91%
VIVUS CAPS Rating: **